Paper: opening our stem cell collection to the world
In the Ooi lab we have over the years grown our induced pluripotent stem cell (iPSC) portfolio. In 2018 we...
Paper: mGluR2/3 agonist LY379268 rescues NMDA and GABAA receptor level deficits induced in a two-hit mouse model of schizophrenia
We published our preclinical antipsychotic study with my PhD supersivors and fellow PhD students. We show with this work, that the...
Paper: Neuregulin 1 prevents phencyclidine-induced behavioral impairments and disruptions to GABAergic signaling in mice
We published the first evidence for an antipsychotic treatment potential of neuregulin 1. Acute neuregulin 1 treatment reduced acute episode-like...
Paper: Negativity towards negative results: a discussion of the disconnect between scientific worth and scientific culture
Our editorial on negativity towards negative results: a discussion of publication bias. Natalie Matosin, Elisabeth Frank, Martin Engel, Jeremy Lum...
Paper: Neuregulin-1 signalling and antipsychotic treatment : Potential therapeutic targets in a schizophrenia candidate signalling pathway
First published review on the direction of our work and its relevance to patients with schizophrenia Deng, Chao, Bo Pan,...